42.89

0.12% 0.05

Veracyte Inc (VCYT)

Overview News Price History Option Chain Financials Discussions Forecast

Veracyte Inc stock is traded at $42.89, with a volume of 804.00K. It is up +0.12% in the last 24 hours and up +29.85% over the past month.

Previous Close:

$42.84

Open:

$43.25

24h Volume:

804.00K

Relative Volume:

1.05

Market Cap:

$1.74B

Revenue:

$399.58M

Net Income/Loss:

$-54.04M

P/E Ratio:

-107.22

EPS:

-0.4

Net Cash Flow:

$40.13M

1W Performance:

+9.41%

1M Performance:

+29.85%

6M Performance:

+106.20%

1Y Performance:

+62.65%

1-Day Range:

$42.35

$44.16

1-Week Range:

$38.13

$44.16

52-Week Range:

$18.61

$44.16

Veracyte Inc Stock (VCYT) Company Profile

Name

Veracyte Inc

Sector

Healthcare (1200)

Industry

Diagnostics & Research (57)

Phone

(650) 243-6300

Address

6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Employee

Twitter

@veracyte

Next Earnings Date

2024-11-06

Latest SEC Filings

VCYT's Discussions on Twitter

Compare VCYT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VCYT Veracyte Inc	42.89	1.74B	399.58M	-54.04M	40.13M	-0.40
TMO Thermo Fisher Scientific Inc	521.66	199.82B	42.37B	6.14B	7.78B	15.26
DHR Danaher Corp	238.83	173.66B	23.74B	3.89B	4.98B	7.93
A Agilent Technologies Inc	138.14	38.64B	6.51B	1.29B	1.37B	3.82
IQV Iqvia Holdings Inc	201.43	36.52B	15.32B	1.41B	1.96B	5.95
IDXX Idexx Laboratories Inc	421.76	34.55B	3.84B	866.24M	792.60M	9.80

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Initiated	Wolfe Research	Outperform
Oct-16-24	Initiated	UBS	Buy
Oct-10-24	Initiated	Guggenheim	Buy
Feb-23-24	Reiterated	Needham	Buy
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Nov-18-21	Resumed	Goldman	Buy
Jun-15-21	Initiated	Raymond James	Outperform
Feb-18-21	Resumed	Needham	Buy
Jan-28-21	Initiated	Truist	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-09-20	Initiated	Morgan Stanley	Underweight
Jul-31-19	Initiated	Lake Street	Buy
Jul-02-19	Initiated	Needham	Buy
Nov-29-18	Downgrade	Janney	Buy → Neutral
Oct-31-18	Upgrade	Janney	Neutral → Buy
Nov-07-17	Downgrade	Janney	Buy → Neutral
Nov-07-17	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-31-17	Resumed	BTIG Research	Buy
Nov-14-16	Resumed	Leerink Partners	Outperform
Dec-18-15	Initiated	Cantor Fitzgerald	Buy
Jun-11-15	Reiterated	Leerink Partners	Outperform
Nov-26-13	Initiated	William Blair	Outperform

View All

Veracyte Inc Stock (VCYT) Latest News

Nov 27, 2024

Veracyte Stock Soars to 52-Week High, Hits $41.46 By Investing.com - Investing.com Nigeria

Nov 27, 2024

Fisher Asset Management LLC Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 27, 2024

Veracyte Stock Soars to 52-Week High, Hits $41.46 - Investing.com India

Nov 27, 2024

Nov 26, 2024

Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Advantage Alpha Capital Partners LP - MarketBeat

Nov 26, 2024

Nov 24, 2024

Algert Global LLC Raises Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 24, 2024

Principal Financial Group Inc. Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 24, 2024

Nov 23, 2024

Veracyte, Inc. (NASDAQ:VCYT) Position Cut by Jennison Associates LLC - MarketBeat

Nov 23, 2024

Nov 22, 2024

Veracyte, Inc. (NASDAQ:VCYT) Position Boosted by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Nov 22, 2024

Nov 21, 2024

Insider Sell Alert: Karin Eastham Sells 14,731 Shares of Veracyte Inc (VCYT) - GuruFocus.com

Nov 21, 2024

Veracyte director Karin Eastham sells shares worth $564,768 By Investing.com - Investing.com Nigeria

Nov 21, 2024

Veracyte director Karin Eastham sells shares worth $564,768 - Investing.com

Nov 21, 2024

Segall Bryant & Hamill LLC Has $15.12 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 21, 2024

Nov 20, 2024

Phocas Financial Corp. Invests $1.79 Million in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 20, 2024

Nov 19, 2024